Equillium Inc (EQ)
Healthcare
Biotechnology
2.20 $
+0.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Equillium Inc (EQ) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -4.3 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -6.2 | -1.9 | -5.7 | -8.8 | 0.7 | -7.7 | -3.3 | -8.2 | -3.0 | -8.4 | -3.1 | -4.3 | -19 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 0.8 | 0.6 | 0.6 | 0.4 | 0.7 | 0.9 | 2.6 | |
| 0.7 | -5.9 | – | – | – | – | – | – | – | – | – | – | – | |
| -1.3 | 2.7 | -1.4 | -4.8 | 4.7 | -1.8 | 2.8 | -0.1 | 2.5 | -4.5 | -0.2 | 0.0 | -2.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 15 | 11 | -5.6 | -2.8 | -1.4 | 12 | 6.0 | 4.5 | – | – | 0.0 | 0.0 | – | |
| – | -0.3 | 0.0 | – | – | 0.1 | 0.0 | – | – | – | – | – | – | |
| -7.7 | – | – | – | – | 0.0 | 0.0 | – | – | – | – | – | – | |
| -7.6 | -0.3 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.0 | 30 | 0.3 | 35 | 66 | |
| 1.1 | 8.8 | -11 | -12 | -0.5 | 4.4 | 2.6 | -3.6 | -3.0 | 22 | -2.8 | 31 | 47 | |
| -6.2 | -1.9 | -5.7 | -8.8 | 0.7 | -7.7 | -3.3 | -8.2 | -3.0 | -8.4 | -3.2 | -4.3 | -19 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.